Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
RADOTINIB TREATMENT IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH RESISTANCE OR INTOLERANCE TO BCR-ABL1 TKIS: 36 MONTHS UPDATE OF RADOTINIB PHASE 2 STUDY
- Authors
- Kim, SH[Kim, S-H.]; Menon, H[Menon, H.]; Jootar, S[Jootar, S.]; Saikia, T[Saikia, T.]; Kwak, JY[Kwak, J-Y.]; Park, JS[Park, J. S.]; Kim, HJ[Kim, H. J.]; Oh, SJ[Oh, S. J.]; Kim, H[Kim, H.]; Zang, DY[Zang, D. Y.]; Park, S[Park, S.]; Park, HL[Park, H. L.]; Lee, GY[Lee, G. Y.]; Cho, DJ[Cho, D. J.]; Shin, JS[Shin, J. S.]; Kim, DW[Kim, D-W.]
- Issue Date
- 26-Jun-2017
- Publisher
- FERRATA STORTI FOUNDATION
- Citation
- HAEMATOLOGICA, v.102, pp.437 - 437
- Indexed
- SCIE
SCOPUS
- Journal Title
- HAEMATOLOGICA
- Volume
- 102
- Start Page
- 437
- End Page
- 437
- ISSN
- 0390-6078
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.